MTOR and cancer: The abnormal activation of PI3K/mTOR signalling is found in some cancers, such as non-small-cell lung cancer, breast cancer, prostate cancer, Burkitt lymphoma, oesophageal adenocarcinoma [123], and colorectal cancer [124].